Henlius’s listing will come amid intensified efforts by China to bring its biotechnology industry on par with international standards. Photo: Handout Henlius’s listing will come amid intensified efforts by China to bring its biotechnology industry on par with international standards. Photo: Handout
Henlius’s listing will come amid intensified efforts by China to bring its biotechnology industry on par with international standards. Photo: Handout

Hong Kong-listed biotech firm Henlius edges closer to Star Market listing

  • ‘We want to make the best medicine in line with the world’s highest standards’, CEO says without revealing time frame or size of listing
  • Company launches biosimilar for treating breast and gastric cancers

Topic |   Shanghai Fosun Pharmaceutical
Henlius’s listing will come amid intensified efforts by China to bring its biotechnology industry on par with international standards. Photo: Handout Henlius’s listing will come amid intensified efforts by China to bring its biotechnology industry on par with international standards. Photo: Handout
Henlius’s listing will come amid intensified efforts by China to bring its biotechnology industry on par with international standards. Photo: Handout
READ FULL ARTICLE